Informations générales (source: ClinicalTrials.gov)
Real-world Effectiveness and Use of UPaDAcitinib in Patients With moderaTE-to-severe Atopic Dermatitis (UPDATE)
Observational
AbbVie (Voir sur ClinicalTrials)
février 2023
février 2027
04 octobre 2024
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to
inflammation of the skin. This study will assess how effective upadacitinib is in
treating AD.
Upadacitinib is an approved drug for treating AD. Approximately 300 adolescent and adult
participants who are prescribed upadacitinib by their physician in accordance with local
label will be enrolled in France.
Participants will receive upadacitinib as prescribed by their physician according to
their routine clinical practice and local label. Participants will be followed up for
approximately 24 months per participant and 30 days after last treatment dose for safety
data collection.
There is expected to be no additional burden for participants in this trial. Participants
will attend regular visits during the study at a hospital or clinic according to their
routine clinical practice.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL NOVO | BEGON | 04/07/2024 11:05:07 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Ambroise Paré | Contact (sur clinicalTrials) | ||||
| AP-HP - Hôpital Bichat | Contact (sur clinicalTrials) | ||||
| AP-HP - Hôpital Cochin | Contact (sur clinicalTrials) | ||||
| AP-HP - Hôpital Henri Mondor-Albert Chenevier | Contact (sur clinicalTrials) | ||||
| AP-HP - Hôpital La Pitié-Salpêtrière | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Cabinet Dermatologie et Esthetique /ID# 247972 - 06400 - Cannes - France | Contact (sur clinicalTrials) | ||||
| Cabinet Liberal /ID# 251195 - 69100 - Villeurbanne - France | Contact (sur clinicalTrials) | ||||
| Cabinet libéral du Dr KURIHARA /ID# 249664 - 75011 - Paris - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier de Béziers /ID# 264454 - 34525 - Béziers - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier de Calais /ID# 249449 - 62100 - Calais - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier de Quimper /ID# 251119 - 29107 - Quimper CEDEX - Finistere - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier de Valenciennes /ID# 258642 - 59300 - Valenciennes - Nord - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier du Mans /ID# 250510 - 72037 - Le Mans CEDEX 9 - Sarthe - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier Métropole Savoie - Site Hôpital de Chambéry /ID# 252012 - 73007 - Chambery CEDEX - Savoie - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier Universitaire de Saint Étienne - Hôpital Nord /ID# 251117 - 42270 - St-Priest-en-Jarez - Haute-Corse - France | Contact (sur clinicalTrials) | ||||
| CH Annecy Genevois - Site Annecy /ID# 249024 - 74370 - Epagny Metz Tessy - France | Contact (sur clinicalTrials) | ||||
| CH Avignon /ID# 251198 - 84902 - Avignon - Vaucluse - France | Contact (sur clinicalTrials) | ||||
| CH de Cahors /ID# 251190 - 46005 - Cahors CEDEX 9 - France | Contact (sur clinicalTrials) | ||||
| CH de PAU /ID# 248567 - 64000 - Pau - France | Contact (sur clinicalTrials) | ||||
| CH de St Nazaire /ID# 251200 - 44600 - Saint Nazaire - France | Contact (sur clinicalTrials) | ||||
| CH Emile Roux Le Puy en Velay /ID# 248983 - 43000 - Le Puy en Velay - France | Contact (sur clinicalTrials) | ||||
| CH Georges Renon /ID# 248976 - 79028 - Niort CEDEX - Deux-Sevres - France | Contact (sur clinicalTrials) | ||||
| CH la Rochelle /ID# 252128 - 17019 - La Rochelle CEDEX 1 - France | Contact (sur clinicalTrials) | ||||
| Ch Saint Quentin /Id# 249270 - 02321 - St Quentin CEDEX - Aisne - France | Contact (sur clinicalTrials) | ||||
| Ch Salon de Provence /Id# 248829 - 13300 - Salon de Provence - France | Contact (sur clinicalTrials) | ||||
| CH Valence /ID# 250693 - 26000 - Valence - Drome - France | Contact (sur clinicalTrials) | ||||
| CH Victor Dupouy /ID# 247216 - 95100 - Argenteuil - France | Contact (sur clinicalTrials) | ||||
| CH William Morey /ID# 256417 - 71321 - Chalon Sur Saone - France | Contact (sur clinicalTrials) | ||||
| CHI POISSY - Saint-Germain-en-Laye /ID# 248612 - 78100 - St Germain en Laye - Yvelines - France | Contact (sur clinicalTrials) | ||||
| CHR Metz-Thionville - Hopital Bel-Air /ID# 252267 - 57100 - Thionville - Haute-Corse - France | Contact (sur clinicalTrials) | ||||
| Chu Angers /Id# 248674 - 49933 - Angers - France | Contact (sur clinicalTrials) | ||||
| CHU Clermont-Ferrand /ID# 248611 - 63100 - Clermont - Auvergne-Rhone-Alpes - France | Contact (sur clinicalTrials) | ||||
| CHU de Besancon - Jean Minjoz /ID# 248642 - 25030 - Besancon - Doubs - France | Contact (sur clinicalTrials) | ||||
| CHU de CAEN - Hopital de la Cote de Nacre /ID# 252127 - 14033 - Caen - France | Contact (sur clinicalTrials) | ||||
| CHU de Nantes, Hotel Dieu -HME /ID# 262563 - 44000 - Nantes - Pays-de-la-Loire - France | Contact (sur clinicalTrials) | ||||
| CHU de Rouen /ID# 250648 - 76031 - Rouen CEDEX - France | Contact (sur clinicalTrials) | ||||
| CHU Dijon /ID# 248984 - 21000 - Dijon - Cote-d Or - France | Contact (sur clinicalTrials) | ||||
| CHU Limoges - Dupuytren 2 /ID# 251224 - 87000 - Limoges - France | Contact (sur clinicalTrials) | ||||
| CHU Montpellier - Hopital Saint Eloi /ID# 251877 - 34295 - Montpellier Cedex 5 - Herault - France | Contact (sur clinicalTrials) | ||||
| CHU nord - hopital Felix Guyon /ID# 250694 - 97400 - St Denis - Le Reunion - France | Contact (sur clinicalTrials) | ||||
| CHU Toulouse - Hopital Larrey /ID# 247219 - 31400 - Toulouse - France | Contact (sur clinicalTrials) | ||||
| Cideazur /ID# 247905 - 06000 - Nice - France | Contact (sur clinicalTrials) | ||||
| HCL - Hopital Lyon Sud /ID# 248864 - 69495 - Pierre Benite CEDEX - Rhone - France | Contact (sur clinicalTrials) | ||||
| Hôpital Charles-Nicolle /ID# 247215 - 76000 - Rouen - France | Contact (sur clinicalTrials) | ||||
| Hôpital d'instruction des armées Bégin /ID# 247751 - 94163 - Saint-Mandé cedex - France | Contact (sur clinicalTrials) | ||||
| Hôpital d'Instruction des Armées Sainte-Anne /ID# 247908 - 83800 - Toulon CEDEX 9 - France | Contact (sur clinicalTrials) | ||||
| Hopital du Scorff /ID# 251226 - 56100 - Lorient - Morbihan - France | Contact (sur clinicalTrials) | ||||
| Hôpital Européen Marseille /ID# 257643 - 13003 - Marseille - Haute-Corse - France | Contact (sur clinicalTrials) | ||||
| Hopital Femme Mere Enfant /ID# 258682 - 69500 - Lyon - France | Contact (sur clinicalTrials) | ||||
| Hopital Nord Amiens /ID# 250300 - 80080 - Amiens - France | Contact (sur clinicalTrials) | ||||
| Hopital Nord Franche Comté /ID# 261628 - 90400 - Trevenans - France | Contact (sur clinicalTrials) | ||||
| Hopital Ponchaillou /ID# 251225 - 35000 - Rennes - Bretagne - France | Contact (sur clinicalTrials) | ||||
| Hopital Prive d'Antony /ID# 247324 - 92160 - Antony - Ile-de-France - France | Contact (sur clinicalTrials) | ||||
| Hopital Saint Joseph /ID# 255537 - 13008 - Marseille - Bouches-du-Rhone - France | Contact (sur clinicalTrials) | ||||
| Hopital Saint Vincent de Paul /ID# 247218 - 59020 - Lille Cedex - France | Contact (sur clinicalTrials) | ||||
| Hôpital Saint-Louis /ID# 251228 - 75010 - Paris - France | Contact (sur clinicalTrials) | ||||
| Hopitaux Drome Nord /ID# 248207 - 26100 - Romans Sur Isere - Drome - France | Contact (sur clinicalTrials) | ||||
| Polyclinique Courlancy /ID# 250476 - 51100 - Reims - Marne - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
- Physician confirmed diagnosis of atopic dermatitis or atopic eczema at baseline.
- Symptom onset ≥1 year prior to baseline.
- Initiation of upadacitinib treatment for AD is indicated and prescribed per local
label.
- The decision to prescribe upadacitinib is made prior to and independently of study
participation.
- Participants who can understand and who are willing and able to complete the
questionnaires, with parental support as required for adolescents.
- Participants (or legal representatives for adolescents) with a smartphone/tablet
with internet access and willing to download the dedicated application to complete
the questionnaires via this application.
- Participants (and legal representatives for adolescents) who have been informed
verbally and in writing about this study before inclusion, and who do not object to
their data being processed.
- Participants (and legal representatives for adolescents) able to understand and
communicate with the investigator.
- Physician confirmed diagnosis of atopic dermatitis or atopic eczema at baseline.
- Symptom onset ≥1 year prior to baseline.
- Initiation of upadacitinib treatment for AD is indicated and prescribed per local
label.
- The decision to prescribe upadacitinib is made prior to and independently of study
participation.
- Participants who can understand and who are willing and able to complete the
questionnaires, with parental support as required for adolescents.
- Participants (or legal representatives for adolescents) with a smartphone/tablet
with internet access and willing to download the dedicated application to complete
the questionnaires via this application.
- Participants (and legal representatives for adolescents) who have been informed
verbally and in writing about this study before inclusion, and who do not object to
their data being processed.
- Participants (and legal representatives for adolescents) able to understand and
communicate with the investigator.
- Participation in a clinical trial assessing an investigational drug, concurrently or
within the last 30 days.
- Prior treatment with upadacitinib.